Five years on, adding relatlimab to nivolumab still helped people with advanced melanoma
Five-year results of the RELATIVITY-047 trial, published Oct. 24, 2026, in Nature Medicine, show that relatlimab plus nivolumab kept improving survival in advanced melanoma compared with nivolumab alone (hazard ratio for death…